Liraglutide ameliorates TAC-induced cardiac hypertrophy and heart failure by upregulating expression level of ANP expression

Recent studies have underscored the cardioprotective properties of liraglutide. This research explores its impact on cardiac hypertrophy and heart failure following transverse aortic constriction (TAC). We found that liraglutide administration markedly ameliorated cardiac hypertrophy, fibrosis, and...

Täydet tiedot

Bibliografiset tiedot

Päätekijät:	Ruisha Li, Keyin Zhang, Zhenjun Xu, Yanrong Yu, Dongjin Wang, Kai Li, Wenxue Liu, Jun Pan
Aineistotyyppi:	Artigo
Kieli:	Inglês
Julkaistu:	Elsevier 2024-06-01
Sarja:	Heliyon
Aiheet:	Liraglutide Cardiac hypertrophy Heart failure ANP ER stress Apoptosis
Linkit:	http://www.sciencedirect.com/science/article/pii/S2405844024082604
Tagit:	Lisää tagi Ei tageja, Lisää ensimmäinen tagi!